Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 185 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR Tambotatug Pelitecan Leads to Better Clinical Outcomes than Topotecan Among Patients with Relapsed SCLC After Platinum-based Therapy ESMO Welcomes European Parliament Calls to Strengthen and Protect Europe’s Cancer Workforce No improvement in OS, but more grade 3 or higher AEs with atezolizumab plus SBRT among patients with inoperable early-stage NSCLC MOST POPULAR What Cancer Caregivers Should Know About Hospice Care at Home: A... August 31, 2021 How Living in Service to Others Helped Me Cope During Cancer March 9, 2023 Man Born Without Legs Proves He’s Greater Than Any Obstacle He’s... December 5, 2021 Political Interests Are A Major Adversary in the War on Women July 6, 2021 Load more HOT NEWS Is there a future without Pap testing? InflaMix Identifies CAR-T Recipients with a Preinfusion Inflammatory Profile Indicative of... EMA Recommends Granting a Marketing Authorisation for Biosimilar Bevacizumab Most Cases of Venous Thromboembolic Events, Elevated Aminotransferases, and Interstitial Lung...
